NKGN

NKGen Biotech, Inc. Common Stock

Delisted

NKGN was delisted on the 4th of March, 2025.

48 hedge funds and large institutions have $123M invested in NKGen Biotech, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$3.39M
2 -$97K
3 -$3.16K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$13.1M
2
$10.9M
3
$5.85M
4
$5.82M
5
$5.1M
6
$4.86M
7
$4.86M
8
$4.86M
9
$4.86M
10
$4.47M
11
$4.03M
12
$3.88M
13
$3.88M
14
$3.54M
15
$3.42M
16
$3.4M
17
$2.93M
18
$2.91M
19
$2.83M
20
$2.48M
21
$2.46M
22
$2.45M
23
$2.37M
24
$1.94M
25
$1.91M